Supercharged Specialty Care

Specialty care is entering a maturation phase where early enthusiasm meets the harder work of proving durable value. Payers are moving from pilot-stage curiosity to demanding multi-year data on cost offsets and clinical outcomes, while CMS refined guardrails around quality standards and appropriate use of remote monitoring, creating clarity, but also raising the bar for market entry. Companies are shifting from growth-at-all-costs to demonstrating sustainable unit economics, deepening clinical rigor, and building the longitudinal evidence base that moves them from "interesting innovation" to "standard of care." Patient capital, disciplined execution, and partnerships with established health systems can provide both credibility and the scale needed to generate actuarial proof, separating platforms with genuine clinical models from those that were primarily distribution plays. Navigate the headwinds or become a case study!